Type 3 diabetes

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Type 3 diabetes | |
|---|---|
| File:Alzheimer's disease brain comparison.jpg | |
| Synonyms | Diabetes type 3, Brain diabetes |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Cognitive decline, memory loss, confusion, dementia |
| Complications | Alzheimer's disease, neurodegeneration |
| Onset | Typically in older adults |
| Duration | Chronic |
| Types | N/A |
| Causes | Insulin resistance in the brain |
| Risks | Type 2 diabetes, obesity, genetic predisposition |
| Diagnosis | Clinical diagnosis, neuroimaging, biomarkers |
| Differential diagnosis | Alzheimer's disease, vascular dementia, Lewy body dementia |
| Prevention | N/A |
| Treatment | Lifestyle changes, medication, cognitive therapy |
| Medication | Insulin, metformin, cholinesterase inhibitors |
| Prognosis | Progressive |
| Frequency | Unknown, associated with Alzheimer's disease |
| Deaths | N/A |
Type 3 diabetes is a term that has been used to describe the proposed link between Alzheimer's disease and insulin resistance in the brain. This concept suggests that Alzheimer's disease may be a form of diabetes that affects the brain, similar to how Type 1 diabetes and Type 2 diabetes affect the body.
Background[edit]
The term "Type 3 diabetes" was first introduced in the early 2000s by researchers who observed that the brains of individuals with Alzheimer's disease showed signs of insulin resistance. Insulin is a hormone that regulates glucose metabolism, and its dysfunction in the brain is thought to contribute to the cognitive decline seen in Alzheimer's patients.
Pathophysiology[edit]
In Type 3 diabetes, the brain's ability to use glucose is impaired due to insulin resistance. This leads to decreased energy production and increased oxidative stress, which can damage neurons and contribute to the development of neurofibrillary tangles and amyloid plaques, hallmark features of Alzheimer's disease.
Risk Factors[edit]
Several risk factors have been associated with the development of Type 3 diabetes, including:
- Genetics: Certain genetic factors may predispose individuals to both insulin resistance and Alzheimer's disease.
- Diet: Poor dietary habits, particularly those high in refined sugars and unhealthy fats, may increase the risk.
- Lifestyle: Sedentary lifestyle and lack of physical activity are known to contribute to insulin resistance.
Prevention and Management[edit]
Preventive measures for Type 3 diabetes focus on improving insulin sensitivity and overall brain health. These include:
- Adopting a Mediterranean diet, which is rich in fruits, vegetables, whole grains, and healthy fats.
- Engaging in regular physical exercise, which can improve insulin sensitivity and cognitive function.
- Managing blood sugar levels through diet and medication if necessary.
Research[edit]
Ongoing research is exploring the mechanisms by which insulin resistance affects the brain and how it can be targeted to prevent or treat Alzheimer's disease. Studies are also investigating the potential use of diabetes medications, such as metformin, in the treatment of Alzheimer's disease.
See also[edit]
References[edit]
- de la Monte, S. M. (2008). "Insulin resistance and Alzheimer's disease." Journal of Alzheimer's Disease, 15(3), 563-569.
- Craft, S. (2005). "Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation." Neurobiology of Aging, 26(1), 65-69.
| Diabetes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Alzheimer's disease topics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Alzheimer's disease related article is a stub.
|